Patent holdings for IPC class C07D 257/04

Total number of patents in this class: 1170

10-year publication summary

118
101
83
73
75
82
76
66
57
17
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Sumitomo Chemical Company, Limited
8808
36
Theravance Biopharma R&D IP, LLC
550
26
Bristol-myers Squibb Company
5080
22
Novartis AG
11238
20
Allergan, Inc.
2600
17
Rigel Pharmaceuticals, Inc.
613
14
Bayer Cropscience AG
2241
12
Nippon Soda Co., Ltd.
890
12
SK Biopharmaceuticals Co., Ltd.
248
12
Pacific Scientific Energetic Materials Company
51
11
Viamet Pharmaceuticals, Inc.
39
11
F. Hoffmann-La Roche AG
7958
10
Global Blood Therapeutics, Inc.
180
10
Zhejiang Huahai Pharmaceutical Co., Ltd.
178
10
Crystal PharmaTech Co., Ltd
87
9
Reata Pharmaceuticals, Inc.
127
9
The Regents of the University of California
18943
8
Boehringer Ingelheim International GmbH
4629
8
Bayer Pharma AG
1096
8
Board of Regents, The University of Texas System
5370
8
Other owners 897